Patients and their treating oncologists are faced with many challenges today, including rising drug prices and the opioid crisis, as well as clinical pathway optimization and algorithms to furthering community oncology engagement in clinical research.
To discuss it all, I sit down with Clifford Hudis, MD, FACP, FASCO, chief executive officer of ASCO, at the recent ASCO annual meeting (2019 meeting in Chicago). In this one-on-one interview, Dr Hudis shares his views and describes how ASCO is working to optimize care delivery for patients amid these challenges in oncology care.
What an honor for me to interview the CEO of the largest oncology society in the world (ASCO); must listen.
This podcast is produced by the Journal of Clinical Pathways.
Dr. Joe Mikhael, Chief Medical Officer of the International Myeloma Foundation (IMF) and Professor at TGen, takes us beyond his medical career to explore the personal experiences that have shaped his journey in oncology. Dr. Mikhael discusses the IMF’s targeted strategies for reducing health disparities among diverse ethnic and racial groups affected by myeloma, shedding
Tom Beer, Chief Medical Officer of the Multi-Cancer Early Detection (MCED) program at Exact Sciences, delves into the groundbreaking science behind MCED tests, which use advanced biomarkers for early detection of multiple cancer types. On this Healthcare Unfiltered episode, he explains who may be eligible for these tests, how to interpret results to avoid unnecessary
In this special episode, I give up the microphone to guest host Kelly Ryerson, who takes over the show asking questions about my new book “The Cancer Journey.”
